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During late summer and autumn 2000, a West Nile fever outbreak in southern France resulted in 76 equine
clinical cases; 21 horses died. We report the results of a large serosurvey of all equines within a 10-km
radius of laboratory-confirmed cases. Blood samples were obtained from 5,107 equines, distributed in
groups of 1 to 91 animals. West Nile virus immunoglobulin (Ig) G antibodies were found in 8.5% of animals
(n=432). Forty-two percent of the IgG-positive animals were also IgM positive. Horses living in small groups
were more affected than those in large groups. The results suggest that West Nile virus is not endemic in the
affected area, the Camargue; rather, sporadic outbreaks are separated by long silent periods.
est Nile virus (WNV) is an arbovirus of the genus Fla-
vivirus, family Flaviridae. Its natural transmission cycle
involves birds and mosquitoes, mainly of the Culex genus.
During late summer and autumn 2000, a WNV outbreak in
southern France resulted in 76 clinical cases in equines; 21
horses died (1). The cases occurred near the Camargue region,
a large wet area that corresponds to the delta of the Rhône
River (Figure 1),  near the Mediterranean coast. The area has a
rich avifauna (2,3); >300 bird species, mostly water birds have
been observed there. Among these species, some are migra-
tory: Camargue is an important resting area for birds migrating
between western Africa and northern Europe. Camargue is
also a breeding area for some species and a wintering area for
others. Mosquito density is high in this wet area (3,4). Among
Culex species, C. pipiens and C. modestus are the most
abundant.
In France, the first reported outbreak occurred in humans
and equines during the summer of 1962 in the south of the
country (5,6). Equine cases occurred both in Camargue
(approximately 30 cases) and in a neighboring dry area (Figure
1; approximately 50 cases). From 1963 through 1964, a sero-
survey was conducted in both areas: 6 of 37 horses were found
positive for WNV (6). 
The 2000 outbreak occurred west of Camargue (Figure 1),
where the landscape features two very different biotopes. The
coast is mainly wet areas with rice fields, numerous ponds, and
marshes. North of these wet areas are dry areas with vineyards,
farming areas, and typical Mediterranean vegetation. Most of
the cases occurred in the dry areas (Figure 1). 
On September 6, 2000, positive serologic results (immuno-
globulin [Ig] G and IgM) were first found in two horse sam-
ples. Two days later, WNV infection was confirmed by
detection of viral RNA in a brain biopsy (1). Clinical cases
were observed until November 2. No abnormal deaths were
observed in birds, and a serosurvey was conducted in Novem-
ber and December 2000 with captive ducks and wild birds
(sparrows, gulls, and magpies). Positive results were found in
one gull, eight ducks, and four magpies (7). Mosquitoes were
also collected in the outbreak area, but none of the pools was
found positive. No human cases were reported; however,
WNV neutralizing antibodies were detected in three game-
keepers working in the area, one of whom also had IgM anti-
bodies (1).
Experimental studies and sequential samples collected
from naturally infected horses have shown that IgM antibodies
become detectable 8–10 days post-infection and persist <2–3
months (8,9). WNV neutralizing antibodies can persist >2
years after infection (9). No published data could be found
about the evolution of the WNV IgG response in horses; how-
ever, IgG neutralizing antibodies may persist several years
after infection.
After the first horse case was confirmed, a serosurvey was
ordered by the animal health authorities on all equines located
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Figure 1. West Nile virus clinical infection in equines in southern
France, 1962–2000.RESEARCH
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within a 10-km radius of laboratory-confirmed clinical cases
(1). Preventive measures included prohibiting movements of
horses inside this perimeter. We report the results of this sero-
survey, the first large-scale serosurvey conducted in equines
worldwide. 
Material and Methods
Blood samples were taken from all the equines within 10
km of the laboratory-confirmed  cases (Figure 1). The use of a
10-km radius area for control measures is common in animal
diseases control plans (e.g., against foot and mouth disease or
classical swine fever). The sera were processed and tested for
WNV IgG and IgM antibodies as described (1). Animals were
first tested for WNV IgG antibodies, and because of logistic
constraints, only positive sera were then tested for IgM anti-
bodies. A positive animal was defined as an IgG-positive ani-
mal. A positive group was defined as a group in which at least
one animal was IgG positive.
For each animal, a form was completed by a veterinarian.
Along with other data (date, names and addresses of the veter-
inarian and the animal caretaker), this form noted the species
and breed of the animal, its age and sex, location, and the size
of the group in which the animal was included on the day the
sample was taken (i.e., the number of equines at the same
place).
The individual serologic results and the data on the forms
were collected in a Microsoft Access database (Microsoft
Corp., Redmond, WA). The horses were grouped by sex (geld-
ings, mares, and stallions) and age (<1 year, 1–2 years, 3–5
years, 6–10 years, 11–15 years, 16–20 years, 21–25 years, and
>25 years). Breeds were grouped into four classes according to
their typical management conditions: the pure breeds (expen-
sive animals kept in stalls at night and pastures by day), the
Camargue breed (an ancient breed of rugged saddle horses or
half-wild animals originating in the survey area, always kept
outside), pony breeds (often living in riding stables and used
every day for short rides) and other breeds (donkeys and other
equines, typically kept outside in small groups on pastures).
Four frequency categories (all having the same number of ani-
mals) were defined for group sizes: 1–2 animals, 3–6 animals,
7–25 animals,  and >25 animals.
Maps were produced with MapInfo software (MapInfo
Corp., Troy, NY). The geographic data describing animal loca-
tions was the name of the “commune,” the smallest adminis-
trative French subdivision, which corresponds to an English
parish.
Statistical analyses were done with SAS software (SAS
Institute Inc., Cary, NC). A bivariate analysis was first per-
formed, crossing each variable (age, sex, breed, and group
size) with the prevalence. The chi square test was calculated
for the four variables. Prevalence ratios were computed for
breed and group size, using the category with the lowest prev-
alence as a reference. For animals groups, chi square tests and
prevalence ratios were computed both at the animal level
(crossing the group size class with the animal-level preva-
lence) and the group level (crossing the group size class with
the group-level prevalence). Finally, a logistic regression was
conducted. Animals for which the age, sex, breed, or group
size had not been indicated were excluded from the data set.
The dependent variable of the model was the serologic status
of animals, and the independent variables were their age class,
sex, breed, and group size. (The location of animals could not
be included in the model because many regression classes
would have been empty.) For each variable, the reference class
was the category with the lowest prevalence.
Results
Descriptive Analyses
Fifty veterinarians took blood samples from 5,107 equines
(4,776 horses and 91 donkeys) distributed in 1,429 groups.
The 14-week serosurvey began on September 16 (week 38)
and ended December 15. The survey area was approximately
2,500 km2 and covered (partially or totally) 99 communes.
The age of 4,749 animals ranged from birth to 40 years.
Half the animals were geldings (48%, n=2,345), 32% were
mares (n=1,533), and 20% were stallions (n=951). Of 53
breeds noted for 4,867 animals, the predominant breed was the
Camargue (36%; n=1,743). Group sizes ranged from 1 to 91
animals, but most of the groups (70%; n=1,006) were small
(1–2 animals). The mean group size was 3.6 animals.
Of the 5,107 animals, 432 were IgG positive (8.5%; 95%
confidence interval [CI] 7.7 to 9.2). Almost half (n=182) were
also IgM positive (42.1%; 95% CI 40.8 to 43.5). The group-
level seroprevalence of the positive groups was higher than the
animal-level seroprevalence: 19.2% (n=274) (95% CI 17.1 to
21.2).
Time Distribution
More than 50% of the samples were taken during the first 3
weeks; 90% of the samples had been taken at the end of week
6 of the study (Figure 2). IgG-positive animals were identified
throughout the 14-week study period: the last positive animals
were found during week 12. Animals that were both IgG- and
Figure 2. West Nile virus serosurvey, Camargue, France, 2000: number
of samples and seropositive animals, by week.Emerging Infectious Diseases  •  Vol. 8, No. 8, August 2002 779
RESEARCH
IgM-positive were also found until week 12, with a slight
decrease over time (15 of 23 during week 1 and 1 of 3 during
week 12).
Geographic Distribution
The map of the number of serum samples per commune
shows that the geographic distribution of horses is not homo-
geneous (Figure 3): fewer samples were taken from horses in
the north of the survey area, where land is more devoted to
vineyards and agriculture, than in the south, in or near wet
areas. The overall animal density is approximately 2 animals
per km2. However, the density in some communes is >16 ani-
mals per km2.
The prevalence by commune (Figure 4) is higher in the
center of the area, as is also the case for the geographic distri-
bution of clinical cases (Figure 1). The main part of this “hot
spot” is not in a wet area, but in a rather dry area. In this focal
point, the prevalence exceeds 30% in eight communes and
reaches 58% in one (28 positive of 48 animals). A similar pat-
tern is found for the group-level seroprevalence, with higher
rates, exceeding 50% in nine communes and reaching 88% in
one, with 21 positive groups of 24. 
Bivariate Analysis
No significant difference was found in the serologic status
of animals according to their distribution by age (chi square
6.63; p=0.47; Table 1) and by sex (chi square 2.65; p=0.27). A
significant difference was found in the serologic status of ani-
mals by breed (chi square=11.12; p=0.01; Table 2), with a
prevalence ratio of 1.5 (95% CI 1.2 to 1.9) for the Camargue
breed. A significant difference was also found in the serologic
status of animals by group size (chi square 54.11; p<0.0001;
Table 3), and decreasing prevalence ratio was observed as
group size increased. At the group level, a significant differ-
ence was also found in the serologic status of groups according
to their distribution by size (chi square 55.68; p<0.0001; Table
4); however, increasing prevalence ratios were observed with
increasing group size.
Logistic Regression Results
The data set used for the logistic regression (animals for
which the age, sex, breed, and group size were known) con-
tained 4,597 records. The reference classes were as follows:
<1 year, mares, other breeds, and >25 animals. A slight effect
was found for the Camargue breed (odds ratio [OR] 1.40; 95%
CI 1.08 to 1.82). Conversely, the main effect was attributed to
the group size variable, with decreasing ORs with increasing
group size: 2.18 for groups of 1–2 animals (95% CI 1.60 to
2.96) and 1.81 for groups of 3–6 animals (Table 5).
Belonging to a small group and, to a lesser extent, being of
the Camargue breed appeared to be risk factors for seropositiv-
ity. Comparison of the eight most affected communes with the
rest of the survey area showed no significant differences by age,
sex, breed, and group size (data not shown). Therefore, these risk
factors are not explained by an overrepresentation of Camargue
horses and of small groups near the epidemic hot spot.
Figure 3. West Nile virus serosurvey, Camargue, France, 2000: geo-
graphic distribution of the animals sampled, by commune (n=5,905).
Figure 4. Immunoglobulin G anti-West Nile virus prevalence in equines,
by commune, Camargue, France, 2000 (n=5,095).
Table 1. Immunoglobulin G anti-West Nile virus prevalence in equines 
by age group, Camargue, France, 2000
Age (yrs) Total Positive (%)
<1 33 2 (6.1)
1–2 368 44 (12.0)
3–5 938 88 (9.4)
6–10 1,559 124 (8.0)
11–15 975 87 (8.9)
16–20 555 50 (9.0)
21–25 229 21 (9.2)
>25 92 9 (9.8)
Total 4,749 425 (8.9)
aChi square = 6.63 (7 degrees of freedom); p=0.47.RESEARCH
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Discussion
Serosurvey Results
The geographic variations of the seroprevalence show that
the epidemic hot spot was not located in a wet area, but several
km to the north, in a rather dry area, even though the horse
density was roughly the same in both areas. Moreover, anti-
bodies were found in 8% of the captive mallards at a large
pond in the south of the perimeter, and in four magpies of 18
captured a few km to the north, near the horse epidemic hot
spot (7). The existence and the specific location of the epi-
demic hot spot could therefore be explained by primary circu-
lation of the virus in water birds in wet areas, followed by an
amplification of this circulation by synanthropic bird species,
involving spread from wet areas to dry areas, where these
birds usually live.
Data analysis showed no age effect. Several serosurveys in
human populations have shown that, when WNV circulation is
endemic in a given area, the seroprevalence tends to increase
with age (10–13). A similar result was found in Egyptian
equines in 1963 (14). However, no such increase was found in
1999 in dogs in New York City, where the virus was thought to
have been absent before that year (15). Assuming that anti-
WNV IgG usually persists several years after infection and
that most of the animals had lived in the survey area for a long
time (and that all age classes are roughly equally exposed to
infecting bites), these results suggest the absence of an
endemic circulation of the WNV in the area. However, the
existence of an endemic transmission cycle, geographically
restricted to marshes (where half-wild horses live that could
not be sampled) cannot be excluded.
A breed effect was observed in that the prevalence was
higher in Camargue horses. This result reflects the usual living
conditions of these rugged horses, always living outside and
therefore more likely to be exposed to infectious bites.
Group size had two opposite effects on seroprevalence,
depending on the unit used for calculation. At the group level,
the increase in seroprevalence with increasing group size is a
classical finding in veterinary epidemiology: assuming all ani-
mals in a given group are exposed to the same low-level prob-
ability of infection, the more animals in the group, the higher
the probability that one (or more) of them become infected. At
the individual level, the decrease of the seroprevalence rate
with increasing group size may be the result of two factors.
First, the sizes of the groups reflect different uses and manage-
ment conditions of the horses: animals kept in large groups
may benefit from better management practices (e.g., stabling
at night, which could reduce their exposure to infecting bites).
However, this result could also reflect a low spatial density of
infectious vectors: assuming a vector does not bite all animals
of a given group but only a few of them, large groups would
have a protective effect. The high density of horses in the area
could also help explain the absence of reported human cases as
a result of a possible zooprophylactic effect of domestic ani-
mals, as pointed out by Komar et al. (15) (domestic animals
may divert infectious bites from human hosts). Because of
lack of data about the primary use and the management condi-
tions of the horses, we could not evaluate the respective
importance of these two factors on the protective effect of
large groups.
Limits and Biases
The survey was intended to be comprehensive for all
equines located <10 km from laboratory-confirmed clinical
cases. Movements of horses in and out of the area probably
occurred at the beginning of the outbreak, before the restric-
tive measures taken by the animal health authorities were in
place. Some of the Camargue horses are half-wild and live
year-round in marshes; for practical reasons, these half-wild
animals were not sampled. However, even if the survey was
not strictly exhaustive, the 5,107-equine sample is certainly
highly representative of the domestic equines in the area.
Having tested only the IgG-positive sera for IgM antibod-
ies is an obvious bias: recently infected animals (with IgM
antibodies but without IgG antibodies) that did not show clini-
cal signs would have been missed. The seroprevalence figures
obtained may be underestimated for domestic equines.
Belonging to the Camargue breed was identified as a seroposi-
tivity risk factor and half-wild animals that were not sampled
belong to this breed; therefore, the seroprevalence rate is prob-
ably also underestimated for the whole equine population of
the area (domestic and half-wild equines).
The geographic distribution of the positive results shows
that, in the east part of the survey area (and to a lesser extent
the west), some positive results were still found near the area
Table 2. Immunoglobulin G anti-West Nile virus prevalence in equines 
by breed, Camargue, France, 2000a
Breed class Total Positive (%) Prevalence ratio 95% CI
Pure breeds 1,252 108 (8.6) 1.2 0.9 to 1.7
Camargue 1,743 183 (10.5) 1.5 1.2 to1.9
Ponies 497 38 (7.6) 1.0 0.7 to1.5
Other 1,375 100 (7.3) Ref.
Total 4,867 429 (8.8)
aChi square=11.12 (3 degrees of freedom), p=0.01; 95% CI = 95% 
confidence intervals.
Table 3. Immunoglobulin G anti-West Nile virus individual-level preva-
lence in equines by group size, Camargue, France, 2000a 
Group size  Total Positive (%) Prevalence ratio 95% CI
1–2 animals 1,353 165 (12.2) 2.2 1.6 to 3.0
3–6 animals 1,118 114 (10.2) 1.8 1.3 to 2.5
7–25 animals 1,355 87 (6.4) 1.1 0.8 to 1.5
>25 animals 1,281 55 (5.1) Ref.
Total 5,107 432 (9.7)
a Chi square = 54.11 (3 degrees of freedom), p<0.0001; 95% CI = 95% confidence inter-
vals.Emerging Infectious Diseases  •  Vol. 8, No. 8, August 2002 781
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boundary: more positive results may have been included if the
perimeter had been larger.
The serosurvey was carried out over a 14-week period;
most of the samples were taken during the first 6 weeks.
Because recent WNV circulation was detected (through IgM-
positive results) until week 12, some animals tested at the
beginning of the study were probably infected later, and the
prevalence might have been higher if the study had been con-
ducted during winter.
Comparison with Other Studies
Few serosurveys have been conducted in equines.  Survey
results can be usefully compared between each other in dis-
ease-endemic areas (14); however, comparison is difficult if
the survey is in epidemic areas. In such areas, the seropreva-
lence rate depends on the definition of the survey perimeter
(which varies between studies). For example, in our study, if a
radius of 15 km around cases had been used to define the sur-
vey perimeter instead of 10 km, the seroprevalence rate proba-
bly would have been lower.
In an endemic area, Egypt in 1959 (14), high seropreva-
lence rates were found, with figures ranging from 36% to 81%.
Conversely, in a newly infected area, New York City in 1999
(15), a much lower rate was found: 2.7% of 71 horses (95% CI
0.3 to 9.5). The seroprevalence we observed is closer to the
latter rate. However, in the Egyptian survey, the 15% seroprev-
alence rate in young horses (<2 yrs) is closer to our result: this
figure better reflects the yearly infection rate and thus the
infection pressure.
The seroprevalence rate can also be compared with the
results of two earlier serosurveys conducted in the studied
area. After the 1962 epidemic (Figure 1), in 37 sera collected
in 1963–1964 from horses that did not have clinical signs the
year before, 6 were positive (16.2%; 95% CI 4.3 to 28.8) (6).
From 1975 to 1979, a low frequency of antibody response
against WNV was observed in 99 horse samples (2%) (16).
Therefore, in the studied region, WNV epidemics may occur
sporadically and be followed by long silent periods.
The results of this study, the first large-scale WNV sero-
survey conducted in equines, show that seroprevalence rate
does not increase with age. Assuming that, as neutralizing
antibodies, IgG antibodies persist several years after infection,
this result (and the WNV history in the studied area since
1962) suggest that the Camargue is an epidemic area, with out-
breaks that occur periodically and are separated by long silent
periods. The seroprevalence level, especially for animal
groups, indicates that virus circulation was intense during the
2000 epidemic. This intense virus circulation and the location
of the epidemic focus in a dry area could be explained by the
amplification by synanthropic bird species in dry areas, from a
primary circulation in wet areas in water birds. The survey
results do not allow us to assert whether this primary circula-
tion is permanent or not (the virus being periodically reintro-
duced by migratory birds). However, the survey results
suggest that, if the primary cycle is permanent, it is restricted
to small marshy areas. Two further studies, a serologic follow-
up of captive ducks and a serosurvey focused on horses living
in the marshy areas, will be conducted in 2001–2002; these
studies should allow us to refine the epidemiologic status of
this primary cycle. 
Table 4. Immunoglobulin G anti-West Nile virus group level preva-
lence in equine groups by group size, Camargue, France, 2000
Size class Total Positive (%) Prevalence ratio 95% CI
1–2 1,006 149 (14.8%) Ref.
3–6 294 73 (24.8%) 1.9 1.4-2.6
7–25 98 40 (40.8%) 4.0 2.6-6.1
>25 31 12 (38.7%) 3.6 1.7-7.6
Total 1,429 274 (19.2%)
a Chi square = 55.68 (3 degrees of freedom), p<0.0001; 95% CI,  95%  confidence inter-
vals.
Table 5. Immunoglobulin G anti-West Nile virus prevalence in 
equines, by age, sex, breed, and group size, Camargue, France, 
2000
Variable OR estimatea 95% CI
Age (years)
<1 Ref
1–2 1.83 0.42 to7.99
3–5 1.39 0.32 to 5.98
6–10 1.13 0.26 to 4.86
11–15 1.25 0.29 to 5.41
16–20 1.24 0.28 to 5.43
21–25 1.20 0.26 to 5.48
>25 1.24 0.25 to 6.15
Sex
Mare Ref.
Gelding 1.13 0.89 to 1.45
Stallion 1.18 0.88 to 1.58
Breed
Pure breeds 1.30 0.97 to 1.74
Camargue 1.40 1.08 to 1.82
Ponies 1.15 0.77 to 1.72
Other Ref.
Group size
1–2 2.18 1.60 to 2.96
3–6 1.81 1.31 to 2.52
7–25 1.09 0.77 to 1.53
>25 Ref.
aOR, odds ratio; 95% CI, 95% confidence intervals.RESEARCH
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